arrow
E

Elisabeth G.E. de Vries

University Medical Centre Groningen
H指数:121
被引数:6.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment

程序性死亡配体1(PD-L1)PET/CT成像评估阿特珠治疗期间肿瘤饱和度

2026-09-100
OAAI
Author Correction: Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study

作者更正:大B细胞淋巴瘤患者治疗前及CD19定向CAR T细胞疗法期间全身CD8+ T细胞PET成像:一项2期研究

2026-02-100
OAAI
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study

大B细胞淋巴瘤患者CD8+ T细胞全身PET成像:在CD19靶向CAR T细胞治疗前后及治疗期间进行的一项2期研究

2025-11-250
OAAI
COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study

COVID-19疫苗在血液系统恶性肿瘤患者中的有效性:一项全国性队列研究

2025-10-010
OAAI
Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer

FES-PET/CT与FDG-PET/CT在ER阳性转移性浸润性小叶乳腺癌患者中的比较分析

2025-09-130
PREAI
Intrapatient 16a-[18F]Fluoro-17b-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer

患者体内16a-[18F]氟-17b-雌二醇PET异质性作为雌激素受体阳性转移性乳腺癌患者内分泌治疗反应和生存的预后因素

2025-01-231
PRE
Phase I study to assess biodistribution of CB307, a trispecific Humabody targeting CD137, prostate-specific membrane antigen, and human serum albumin with 89Zr-CB307 PET

I期研究评估CB307的生物分布情况,CB307是一种靶向CD137、前列腺特异性膜抗原和人血清白蛋白的三特异性Humabody,并通过89Zr-CB307 PET进行检测。

2024-09-010
PRE
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy
2024-08-271
OAAI